The winners and losers of Biden’s plans to expand coverage of weight-loss drugs US President Joe Biden wants to expand the ...

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

The Biden administration announced Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Data gathered from the Central Disease Center and the American Diabetes highlights a health crisis in Arkansas.

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Men with heart risk factors tend to lose their brain health more quickly than women with similar heart risks, a new study ...